A 3,5-dioxa-12-azawurtzitane compound represented by the formula (I) shown
in the specification. The dioxaazawurtzitane compound may be prepared by
reacting an amino acid, an oligo- or polypeptide or a polyamino acid with
a trialdehyde represented by formula (II) shown in the specification.